Post Tagged with: "EARS"

Momentum Stocks: Neostem (NASDAQ:NBS), Auris Medical Holding AG (NASDAQ:EARS), Baxter International Inc. (NYSE:BAX), Violin Memory (NYSE:VMEM), Senomyx Inc. (NASDAQ:SNMX)

May 15, 2015 at 1:12 pm 0 comments

On Thursday shares of Neostem, Inc. (NASDAQ:NBS) closed at $2.31. Company’s sales growth for last 5 years was 9.10%. On May 5 Neostem, Inc. (NASDAQ:NBS), announced 2015 first quarter results and provided an update on its business. Total revenue forRead More

Today’s Watch List: Auris Medical Holding AG (NASDAQ:EARS), China Techfaith Wireless Comm (NASDAQ:CNTF), Randgold Resources (NASDAQ:GOLD), Bank of Commerce (NASDAQ:BOCH), TransCanada (NYSE:TRP)

May 13, 2015 at 2:02 pm 0 comments

On Tuesday shares of Auris Medical Holding AG (NASDAQ:EARS) closed at $5.58. Auris Medical Holding AG (Nasdaq:EARS) on 4 May, provided an update on the clinical development of its AM-111 product candidate. AM-111 is being developed for the treatment ofRead More

Why Need to Watch: Flamel Technologies (NASDAQ:FLML), Auris Medical (NASDAQ:EARS), National Western Life Insurance (NASDAQ:NWLI), Leucadia National (NYSE:LUK), Nordic American Offshore (NYSE:NAO)

May 11, 2015 at 1:57 pm 0 comments

On Friday shares of Flamel Technologies SA (NASDAQ:FLML) closed at $16.27. Company’s sales growth for last 5 years was -18.90% and EPS growth for next 5 years is recorded as 34.00%. On May 06, Flamel Technologies SA (NASDAQ:FLML) said itRead More

Today’s Hot List: Theravance Biopharma (NASDAQ:TBPH), Auris Medical Holding AG (NASDAQ:EARS), Ohio Valley Banc Corp. (NASDAQ:OVBC), Korn/Ferry International (NYSE:KFY), FutureFuel (NYSE:FF)

May 8, 2015 at 5:34 am 0 comments

On Wednesday shares of Theravance Biopharma, Inc. (NASDAQ:TBPH) closed at $15.51. Company’s EPS growth for next 5 years is recorded as 8.80%. On May 04, Theravance Biopharma, Inc. (NASDAQ:TBPH) announced that stock options to purchase an aggregate of 7,900 ofRead More

Active Stocks: Evogene (NYSE:EVGN), Auris Medical Holding AG (NASDAQ:EARS), Cloud Peak Energy Inc. (NYSE:CLD), Facebook Inc (NASDAQ:FB), Kinross Gold Corporation (NYSE:KGC)

May 6, 2015 at 12:57 pm 0 comments

On Tuesday shares of Evogene Ltd. (NYSE:EVGN) closed at $10.01. Evogene Ltd. (NYSE:EVGN) announced that it will release its financial results for the first quarter 2015 on Tuesday, May 19, 2015. Auris Medical Holding AG (NASDAQ:EARS) in last trading activityRead More

Big Movers: Auris Medical (NASDAQ:EARS), Halcon Resources Corporation (NYSE:HK), Delta Air Lines (NYSE:DAL), Mueller Water Products (NYSE:MWA), WesBanco Inc. (NASDAQ:WSBC)

May 5, 2015 at 1:46 pm 0 comments

On Monday shares of Auris Medical Holding AG (NASDAQ:EARS) closed at $5.82. Zacks cut shares of Auris Medical Holding AG (NASDAQ:EARS) from a buy rating to a hold rating in a research note issued to investors on Friday. Halcon ResourcesRead More

Today’s Stocks: Home Loan Servicing Solutions, (NASDAQ:HLSS), Auris Medical Holding AG (NASDAQ:EARS), Express Scripts (NASDAQ:ESRX), Facebook (NASDAQ:FB), Clayton Williams Energy (NYSE:CWEI)

April 9, 2015 at 1:36 pm 0 comments

On Wednesday shares of Home Loan Servicing Solutions, Ltd. (NASDAQ:HLSS) closed at $17.14. Company’s EPS growth for next 5 years is recorded as 5.00%. On 6 April, Home Loan Servicing Solutions, Ltd. (NASDAQ:HLSS) and New Residential Investment Corp. (NYSE: NRZ)Read More

Investors Should Watch: Auris Medical Holding AG (NASDAQ:EARS), Pfizer Inc. (NYSE:PFE), Knight Transportation Inc. (NYSE:KNX), Williams Partners L.P. (NYSE:WPZ), TELUS Corporation (NYSE:TU)

February 9, 2015 at 1:22 pm 0 comments

Auris Medical Holding AG (NASDAQ:EARS) announced that Thomas Meyer, Ph.D., Chairman and CEO, will present at the Leerink Global Healthcare Conference on Wednesday, February 11, 2015 at 2:15 p.m. EST at the Waldorf Astoria Hotel in New York. On FridayRead More

Trader’s Alert: Auris Medical Holding AG (NASDAQ:EARS), Majesco Entertainment Co. (NASDAQ:COOL), Penn West Petroleum (NYSE:PWE), Hudson Global, Inc (NASDAQ:HSON), StemCells (NASDAQ:STEM)

January 30, 2015 at 2:40 pm 0 comments

On Jan 14, Auris Medical Holding AG (NASDAQ:EARS) announced that it has enrolled the first 150 patients with post-acute tinnitus in Stratum B of the Company’s ongoing TACTT3 clinical trial, representing fifty percent of the target enrolment in this Stratum.Read More

Trader’s Buzz: Paratek Pharmaceuticals (NASDAQ:PRTK), Auris Medical Holding (NASDAQ:EARS), CEMEX, S.A.B. de C.V. (NYSE:CX), AAON Inc. (NASDAQ:AAON), Brightcove (NASDAQ:BCOV)

December 11, 2014 at 1:28 pm 0 comments

Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK), a late stage antibiotics company, on 3 December said Douglas Pagán would join its executive leadership team as chief financial officer, effective December 18. He will report to Michael Bigham, Chairman and Chief Executive Officer ofRead More